IL10 and Parkinson disease: Our results showed that the levels of TNF-α, IL-1β, and IL-6 expression in PD patients with anti-PD medications were slightly lower than that of untreated patients, while the levels of IL-4 and IL-10 expression in PD with all types of anti-PD medications were slightly higher than that of untreated PD.